NCT06495944View on ClinicalTrials.gov

Impact of Itraconazole on the Pharmacokinetics and Safety of Dazucorilant in Healthy, Adult Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

May 31, 2024

Primary Completion Date

August 2, 2024

Study Completion Date

August 2, 2024

Conditions
Healthy Adults
Interventions
DRUG

Dazucorilant

75 mg soft gelatin capsules formulation for oral administration

DRUG

Itraconazole

100 mg capsules for oral administration

Trial Locations (1)

21201

Site 01, Baltimore

Sponsors
All Listed Sponsors
lead

Corcept Therapeutics

INDUSTRY